TGFB1 and cancer: However, under pathological conditions including cancer, IMC differentiation is inhibited resulting in the accumulation and activation of immunosuppressive MDSCs by the production of immune suppressive factors such as arginase I, inducible nitric oxidase synthase and TGF-β from the IMCs [112].